BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  argenx Reports First Quarter 2023 Financial Results and Provides Business Update

  argenx SE, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced its first quarter 2023 financial results and provided a business update.

  May 4, 2023

   · 

  14 min read
• FDA

  FoundationOne®Liquid CDx Receives FDA-Approval as a Companion Diagnostic for EXKIVITY® (mobocertinib) to Identify Patients with EGFR Exon 20 Insertion Mutations in Advanced Non-Small Cell Lung Cancer

  Foundation Medicine, Inc., a leader in molecular profiling for cancer, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®Liquid CDx to be used as a companion diagnostic for EXKIVITY® (mobocertinib).

  May 4, 2023

   · 

  11 min read
• Biotech Bay

  CHMP Adopts Positive Opinion Recommending Hepcludex® (Bulevirtide) for Full Marketing Authorization for the Treatment of Hepatitis Delta Virus (HDV)

  CHMP Adopts Positive Opinion Recommending Hepcludex ® (Bulevirtide) for Full Marketing Authorization for the Treatment of Hepatitis Delta Virus (HDV).

  May 4, 2023

   · 

  6 min read
• Business

  Zoetis Announces First Quarter 2023 Results

  Zoetis Inc. (NYSE: ZTS) today reported its financial results for the first quarter of 2023 and maintained its guidance for full year 2023.

  May 4, 2023

   · 

  24 min read
• Business

  Bruker Reports First Quarter 2023 Financial Results

  Bruker Corporation quarter ended March 31, 2023.

  May 4, 2023

   · 

  20 min read
• Business

  VitalHub Announces Q1 2023 Conference Call Date

  VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX:VHIBF) is pleased to announce that it will release its financial results for its quarter ended March 31st , 2023, after market close on May 11th , 2023.

  May 4, 2023

   · 

  3 min read
• Business

  Intellia Therapeutics Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress

  Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapies leveraging CRISPR-based technologies, today reported operational highlights and financial results for the first quarter ended March 31, 2023.

  May 4, 2023

   · 

  16 min read
• Business

  Selecta Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update

  Selecta Biosciences, Inc. today reported financial results for the first quarter ended March 31, 2023 and provided a business update.

  May 4, 2023

   · 

  12 min read
• Business

  Intra-Cellular Therapies Reports First Quarter 2023 Financial Results and Provides Corporate Update

  Intra-Cellular Therapies, Inc. today announced its financial results for the first quarter ended March 31, 2023 and provided a corporate update.

  May 4, 2023

   · 

  17 min read
• Business

  Arbutus Reports First Quarter 2023 Financial Results and Corporate Update

  Arbutus Biopharma Corporation today reported first quarter 2023 financial results and provided a corporate update.

  May 4, 2023

   · 

  17 min read